MedPath

Study of oral zinc supplementation effect on type 2 diabetes

Phase 3
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20150831023838N1
Lead Sponsor
Endocrinology and metabolism research institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Afflicted with type 2 diabetes mellitus
BMI= 25-30 kg/m2
HbA1c =7

Exclusion Criteria

Smoking
Taking diuretics
Taking antibiotics
Taking multivitamins containing zinc
Gastrointestinal disorders
Thyroid disorders
Cancer history
Renal disorders
Liver disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath